Vetter has announced that in keeping with its commitment to providing customers with the manufacture of high quality drug products, the company will invest approximately 300 million euros to expand and upgrade its manufacturing facilities over an estimated five-year period. As a leading con ... more
At a meeting in September, the Supervisory Board of Analytik Jena AG made the decision to expand the Company’s Executive Board. In this way, the Company is responding to its growth and the ever-increasing challenges associated with its operational business. The management body of the Jena-b ... more
Based on measurements of radioactivity in samples of infant formula manufactured and sold around the world, researchers estimate that infants 1 year of age or younger who consume these formulas would ingest a significantly higher radioactivity dose than reported levels, but lower than inter ... more
Researchers from Queen Mary University of London (QMUL) are calling on the medical community to reconsider developing a known drug to treat people with relapsing Multiple sclerosis (MS) after new evidence shows it does not increase the risk of cancer as previously thought.
The drug called C ... more
A team of Virginia Tech researchers has refined a mathematical model that simulates the impact of genetic mutations on cell division -- a step that could provide insight into errors that produce and sustain harmful cells, such as those found in tumors.
In a study the group detailed their fi ... more
Almost half of patients with advanced lung cancer receive more than the recommended number of radiation treatments to reduce their pain, according to a new study.
Radiation therapy that is palliative, or not intended to cure, can reduce the pain from lung tumors and improve quality of life. ... more
In a phase Ia clinical trial, immune cells called Tregs, which can inhibit anticancer immune responses, were efficiently eliminated from the blood of patients with lung or esophageal cancer by treatment with the investigational therapeutic antibody KW-0761.
Author(s): Ryuzo Ueda, MD, PhD, p ... more
To treat children with a missing or under-developed ear, experienced surgeons harvest pieces of rib cartilage from the child and carve them into the framework of a new ear. They take only as much of that precious cartilage as they need.
That leaves medical residents without an authentic mat ... more
Merck announced that it has reached an agreement with BioMarin Pharmaceutical, Inc., San Rafael, California, U.S., to return the rights to Kuvan, used to treat phenylketonuria (PKU), a rare metabolism disorder, as the company focuses its healthcare business on core areas. In addition to Kuv ... more
Merck expects the Latin America region to keep driving growth at its Consumer Health business, as demand for consumer goods in the region is constantly rising.
“Along with a growing consumer demand, Latin America sees a rise in the need for healthcare products and a trend towards consumer g ... more